IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. 2006

Katsuaki Hoshino, and Takahiro Sugiyama, and Mitsuru Matsumoto, and Takashi Tanaka, and Masuyoshi Saito, and Hiroaki Hemmi, and Osamu Ohara, and Shizuo Akira, and Tsuneyasu Kaisho
Laboratory for Host Defense, RIKEN Research Center for Allergy and Immunology, Suehiro-cho 1-7-22, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.

The Toll-like receptor (TLR) family has important roles in microbial recognition and dendritic cell activation. TLRs 7 and 9 can recognize nucleic acids and trigger signalling cascades that activate plasmacytoid dendritic cells to produce interferon-alpha (IFN-alpha) (refs 7, 8). TLR7/9-mediated dendritic cell activation is critical for antiviral immunity but also contributes to the pathogenesis of systemic lupus erythematosus, a disease in which serum IFN-alpha levels are elevated owing to plasmacytoid dendritic cell activation. TLR7/9-induced IFN-alpha induction depends on a molecular complex that contains a TLR adaptor, MyD88, and IFN regulatory factor 7 (IRF-7) (refs 10-14), but the underlying molecular mechanisms are as yet unknown. Here we show that IkappaB kinase-alpha (IKK-alpha) is critically involved in TLR7/9-induced IFN-alpha production. TLR7/9-induced IFN-alpha production was severely impaired in IKK-alpha-deficient plasmacytoid dendritic cells, whereas inflammatory cytokine induction was decreased but still occurred. Kinase-deficient IKK-alpha inhibited the ability of MyD88 to activate the Ifna promoter in synergy with IRF-7. Furthermore, IKK-alpha associated with and phosphorylated IRF-7. Our results identify a role for IKK-alpha in TLR7/9 signalling, and highlight IKK-alpha as a potential target for manipulating TLR-induced IFN-alpha production.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon
D048868 Adaptor Proteins, Signal Transducing A broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes Signal Transducing Adaptor Proteins
D051199 Toll-Like Receptor 7 A pattern recognition receptor that binds several forms of imidazo-quinoline including the antiviral compound Imiquimod. TLR7 Receptor,Receptor, TLR7,Toll Like Receptor 7

Related Publications

Katsuaki Hoshino, and Takahiro Sugiyama, and Mitsuru Matsumoto, and Takashi Tanaka, and Masuyoshi Saito, and Hiroaki Hemmi, and Osamu Ohara, and Shizuo Akira, and Tsuneyasu Kaisho
December 2008, Journal of virology,
Katsuaki Hoshino, and Takahiro Sugiyama, and Mitsuru Matsumoto, and Takashi Tanaka, and Masuyoshi Saito, and Hiroaki Hemmi, and Osamu Ohara, and Shizuo Akira, and Tsuneyasu Kaisho
November 2010, The Journal of experimental medicine,
Katsuaki Hoshino, and Takahiro Sugiyama, and Mitsuru Matsumoto, and Takashi Tanaka, and Masuyoshi Saito, and Hiroaki Hemmi, and Osamu Ohara, and Shizuo Akira, and Tsuneyasu Kaisho
January 2009, Journal of medicinal chemistry,
Katsuaki Hoshino, and Takahiro Sugiyama, and Mitsuru Matsumoto, and Takashi Tanaka, and Masuyoshi Saito, and Hiroaki Hemmi, and Osamu Ohara, and Shizuo Akira, and Tsuneyasu Kaisho
February 2008, European journal of immunology,
Katsuaki Hoshino, and Takahiro Sugiyama, and Mitsuru Matsumoto, and Takashi Tanaka, and Masuyoshi Saito, and Hiroaki Hemmi, and Osamu Ohara, and Shizuo Akira, and Tsuneyasu Kaisho
December 2007, Biochemical Society transactions,
Katsuaki Hoshino, and Takahiro Sugiyama, and Mitsuru Matsumoto, and Takashi Tanaka, and Masuyoshi Saito, and Hiroaki Hemmi, and Osamu Ohara, and Shizuo Akira, and Tsuneyasu Kaisho
December 2007, The Journal of biological chemistry,
Katsuaki Hoshino, and Takahiro Sugiyama, and Mitsuru Matsumoto, and Takashi Tanaka, and Masuyoshi Saito, and Hiroaki Hemmi, and Osamu Ohara, and Shizuo Akira, and Tsuneyasu Kaisho
January 2014, FEBS letters,
Katsuaki Hoshino, and Takahiro Sugiyama, and Mitsuru Matsumoto, and Takashi Tanaka, and Masuyoshi Saito, and Hiroaki Hemmi, and Osamu Ohara, and Shizuo Akira, and Tsuneyasu Kaisho
March 2011, Immunity,
Katsuaki Hoshino, and Takahiro Sugiyama, and Mitsuru Matsumoto, and Takashi Tanaka, and Masuyoshi Saito, and Hiroaki Hemmi, and Osamu Ohara, and Shizuo Akira, and Tsuneyasu Kaisho
May 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Katsuaki Hoshino, and Takahiro Sugiyama, and Mitsuru Matsumoto, and Takashi Tanaka, and Masuyoshi Saito, and Hiroaki Hemmi, and Osamu Ohara, and Shizuo Akira, and Tsuneyasu Kaisho
February 2023, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Copied contents to your clipboard!